Cargando…
Steps toward nebulization in-use studies to understand the stability of new biological entities
The need for novel biological drugs against respiratory diseases has been highlighted during the Coronavirus (COVID-19) pandemic. The use of inhalation presents challenges to drug product stability, which is especially true for delivery using nebulizers (jet versus mesh technologies). The late-stage...
Autor principal: | Montefusco-Pereira, Carlos Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770090/ https://www.ncbi.nlm.nih.gov/pubmed/36455828 http://dx.doi.org/10.1016/j.drudis.2022.103461 |
Ejemplares similares
-
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
por: Saifi, Mohd Aslam, et al.
Publicado: (2022) -
Nanomedicine approaches to reduce cytokine storms in severe infections
por: Ahmar Rauf, Mohd, et al.
Publicado: (2022) -
Impact of COVID-19 on male urogenital health: Success of vaccines
por: Kucukyildiz, Kutay, et al.
Publicado: (2022) -
Harnessing aptamers against COVID-19: A therapeutic strategy
por: Mahmoudi, Ali, et al.
Publicado: (2023) -
Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021)